Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 105120, 12 pages
http://dx.doi.org/10.1155/2014/105120
Research Article

Diethylcarbamazine Attenuates the Development of Carrageenan-Induced Lung Injury in Mice

1Pós-Graduação em Ciências Biológicas da Universidade Federal de Pernambuco, Avenida Professor Moraes Rego, s/n, Cidade Universitária, 50670-901 Recife, PE, Brazil
2Instituto Aggeu Magalhães, FIOCRUZ, Avenida Professor Moraes Rego, s/n, Cidade Universitária, 50670-420 Recife, PE, Brazil
3Departamento de Morfologia e Fisiologia Animal da Universidade Federal Rural de Pernambuco, Rua Dom Manoel de Medeiros, s/n, Dois Irmãos, 52171-900 Recife, PE, Brazil
4Laboratório de Ultraestrutura, Instituto Aggeu Magalhães, FIOCRUZ, Avenida Professor Moraes Rego, s/n, Cidade Universitária, 50670-420 Recife, PE, Brazil

Received 19 July 2013; Accepted 3 December 2013; Published 16 January 2014

Academic Editor: Tânia Fröde

Copyright © 2014 Edlene Lima Ribeiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. I. S. Hewitt, H. W. Kushner, E. Stewart, W. S. White, and Y. Wallace, “Experimental chemotherapy of filariasis. III. Effect of 1-diethylcarbamyl-4-methylpiperazine hydrochloride against naturally acquired filarial infections in cotton rats and dogs,” Journal of Laboratory and Clinical Medicine, vol. 32, pp. 1314–1329, 1947. View at Google Scholar · View at Scopus
  2. R. M. Maizels and D. A. Denham, “Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug,” Parasitology, vol. 105, pp. 849–860, 1992. View at Google Scholar · View at Scopus
  3. W. R. Mathews and R. C. Murphy, “Inhibition of leukotriene biosynthesis in mastocytoma cells by diethylcarbamazine,” Biochemical Pharmacology, vol. 31, no. 11, pp. 2129–2132, 1982. View at Publisher · View at Google Scholar · View at Scopus
  4. M. K. Bach and J. R. Brashler, “Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine, and synergism between diethylcarbamazine and piriprost, a 5-lipoxygenase inhibitor,” Biochemical Pharmacology, vol. 35, no. 3, pp. 425–433, 1986. View at Google Scholar · View at Scopus
  5. H. V. Srinivas and J. Antani, “Diethylcarbamazine in bronchial asthma,” Annals of Allergy, vol. 29, no. 8, pp. 418–421, 1971. View at Google Scholar · View at Scopus
  6. K. V. Thiruvengadam, N. Subramanian, T. V. Devarajan, and M. G. M. Zachariah, “Diethylcarbamazine citrate in bronchial asthma,” Journal of the Indian Medical Association, vol. 63, no. 9, pp. 278–281, 1974. View at Google Scholar · View at Scopus
  7. T. Queto, P. Xavier-Elsas, M. A. Gardel et al., “Inducible nitric oxide synthase/CD95L-dependent suppression of pulmonary and bone marrow eosinophilia by diethylcarbamazine,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 5, pp. 429–437, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Impellizzeri, E. Esposito, E. Mazzon et al., “Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation,” Biochemical Pharmacology, vol. 81, no. 5, pp. 636–648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Tomlinson, I. Appleton, A. R. Moore et al., “Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy,” British Journal of Pharmacology, vol. 113, no. 3, pp. 693–698, 1994. View at Google Scholar · View at Scopus
  10. J. Vane and R. Botting, “Inflammation and the mechanism of action of anti-inflammatory drugs,” The FASEB Journal, vol. 1, no. 2, pp. 89–96, 1987. View at Google Scholar · View at Scopus
  11. E. M. Dalmarco, Y. S. Medeiros, and T. S. Fröde, “Cyclosporin A inhibits CD11a/CD18 adhesion molecules due to inhibition of TNFalpha and IL-1 beta levels in the mouse model of pleurisy induced by carrageenan,” Cell Adhesion & Migration, vol. 2, no. 4, pp. 231–235, 2008. View at Google Scholar · View at Scopus
  12. K. P. Barbosa, L. A. Santos, E. L. Ribeiro et al., “Reduction of carrageenan-induced acute pulmonary inflammation in mice by novel thiazolidinedione derivative LPSF/RA-4,” European Journal of Pharmacology, vol. 718, no. 1–3, pp. 197–205, 2013. View at Publisher · View at Google Scholar
  13. C. Crisafulli, E. Mazzon, I. Paterniti, M. Galuppo, P. Bramanti, and S. Cuzzocrea, “Effects of liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation,” Respiratory Research, vol. 11, article 19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Nantel, D. Denis, R. Gordon et al., “Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation,” British Journal of Pharmacology, vol. 128, no. 4, pp. 853–859, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. World Health Organization, “Global programme to eliminate lymphatic filariasis,” Annual Report on Lymphatic Filariases 113, Geneva, Switzerland, 2002. View at Google Scholar
  16. A. H. M. Terpstra, “Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate,” Journal of Nutrition, vol. 131, no. 7, pp. 2067–2068, 2001. View at Google Scholar · View at Scopus
  17. E. M. Dalmarco, P. Budni, E. B. Parisotto, D. W. Filho, and T. S. Frode, “Antioxidant effects of mycophenolate mofetil in a murine pleurisy model,” Transplant Immunology, vol. 22, no. 1-2, pp. 12–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Menegazzi, R. di Paola, E. Mazzon et al., “Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice,” Pharmacological Research, vol. 58, no. 1, pp. 22–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. L. A. Saraiva, V. A. Silva Jr., E. S. F. Dias, and C. A. Peixoto, “Morphological changes in the testis induced by diethylcarbamazine,” Reproductive Toxicology, vol. 22, no. 4, pp. 754–759, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. K. L. A. Saraiva, A. K. S. Silva, M. I. Wanderley, A. A. Araújo, J. R. B. Souza, and C. A. Peixoto, “Chronic treatment with sildenafil stimulates Leydig cell and testosterone secretion,” International Journal of Experimental Pathology, vol. 90, no. 4, pp. 454–462, 2009. View at Publisher · View at Google Scholar
  21. K. M. Mullane, R. Kraemer, and B. Smith, “Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium,” Journal of Pharmacological Methods, vol. 14, no. 3, pp. 157–167, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Guevara, J. Iwanejko, A. Dembińska-Kieć et al., “Determination of nitrite/nitrate in human biological material by the simple Griess reaction,” Clinica Chimica Acta, vol. 274, no. 2, pp. 177–188, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. M. A. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 240–254, 1970. View at Google Scholar · View at Scopus
  24. S. Cuzzocrea, L. Sautebin, G. de Sarro et al., “Role of IL-6 in the pleurisy and lung injury caused by carageenan,” Journal of Immunology, vol. 163, no. 9, pp. 5094–5104, 1999. View at Google Scholar · View at Scopus
  25. S. Cuzzocrea, E. Mazzon, G. Calabro et al., “Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 5, pp. 1859–1866, 2000. View at Google Scholar · View at Scopus
  26. E. Talero, R. di Paola, E. Mazzon, E. Esposito, V. Motilva, and S. Cuzzocrea, “Anti-inflammatory effects of adrenomedullin on acute lung injury induced by Carrageenan in mice,” Mediators of Inflammation, vol. 2012, Article ID 717851, 13 pages, 2012. View at Publisher · View at Google Scholar
  27. H. Nomura, E. Sato, S. Koyama et al., “Histamine stimulates alveolar macrophages to release neutrophil and monocyte chemotactic activity,” Journal of Laboratory and Clinical Medicine, vol. 138, no. 4, pp. 226–235, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. K. R. Stenmark, M. L. Morganroth, L. K. Remigio et al., “Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension,” The American journal of physiology, vol. 248, no. 6, part 2, pp. H859–H866, 1985. View at Google Scholar · View at Scopus
  29. T. S. F. Saleh, J. B. Calixto, and Y. S. Medeiros, “Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan,” Peptides, vol. 20, no. 8, pp. 949–956, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Sakaguchi, H. Shirahase, K. Kunishiro, A. Ichikawa, M. Kanda, and Y. Uehara, “Effect of combination of nitric oxide synthase and cyclooxygenase inhibitors on carrageenan-induced pleurisy in rats,” Life Sciences, vol. 79, no. 5, pp. 442–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Salvemini, P. Z. Manning, B. S. Zweifel et al., “Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors,” The Journal of Clinical Investigation, vol. 96, no. 1, pp. 301–308, 1995. View at Google Scholar · View at Scopus
  32. L. Sautebin, A. Ialenti, A. Ianaro, and M. di Rosa, “Relationship between nitric oxide and prostaglandins in carrageenin pleurisy,” Biochemical Pharmacology, vol. 55, no. 7, pp. 1113–1117, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Sano, T. Hla, J. Maier et al., “In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis,” The Journal of Clinical Investigation, vol. 89, no. 1, pp. 97–108, 1992. View at Google Scholar · View at Scopus
  34. R. M. Clancy and S. B. Abramson, “Nitric oxide: a novel mediator of inflammation,” Proceedings of the Society for Experimental Biology and Medicine, vol. 210, no. 2, pp. 93–101, 1995. View at Google Scholar · View at Scopus
  35. H. F. Mcgarry, L. D. Plant, and M. J. Taylor, “Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway,” Filaria Journal, vol. 4, article 4, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. F. A. J. van de Loo, O. J. Arntz, and W. B. van den Berg, “Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis,” Cytokine, vol. 9, no. 7, pp. 453–462, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Cuzzocrea, B. Zingarelli, P. Hake, A. L. Salzman, and C. Szabo, “Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation,” Free Radical Biology and Medicine, vol. 24, no. 3, pp. 450–459, 1998. View at Publisher · View at Google Scholar · View at Scopus